Crossover RCT in 30 healthy volunteers: all cebranopadol and oxycodone doses depressed breathing vs placebo, with cebranopadol 600 µg causing less respiratory depression than oxycodone 30 mg (P=0.022); desaturations in 25% vs 65% at top doses.
RCTn = 30
Jansen et al. Respiratory and Antinociceptive Effects of Nociceptin Receptor-µ-Opioid Receptor Agonist Cebranopadol versus Full Opioid Receptor Agonist Oxycodone: A Comparison in Healthy Volunteers